pharma · Metastatic Breast Cancer
Forward Pharmaceuticals Co
Forward Pharmaceuticals Co.,
Forward Pharmaceuticals Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Metastatic Breast Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent recor
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
FWD1802
Phase 2 · small molecule · Metastatic Breast Cancer
FWD1802 for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Forward Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Internal code FWD1802-001C
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Forward Pharmaceuticals Co.,
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Metastatic Breast Cancer
- Status
- active
- Trials
- 1